Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

Withdrawal of Voxelotor: Implications for Clinical Practice in Sickl…

Akshat Jain

Managing Benign Hematology Disorders

Indy Hematology Review

C. Kessler

Understanding CRISPR and Gene Editing in the Treatment of Heme Malig…

UChicago Medicine

A. Cooper

How to Approach Anemia

Icahn School of Medicine at Mount Sinai

C. Cromwell

ASH 2024 Review: AI in Classical Hematology

Cleveland Clinic Taussig Cancer Institute

R. Patell

Sickle Cell Disease Updates: Clinical Trials, Current Therapies, and…

Marwan Shaikh

Sickle Cell Disease Updates: Incidence, Barriers, Survival Rates, an…

Marwan Shaikh

ASH 2024 Review: Updates in Sickle Cell Disease

Cleveland Clinic Taussig Cancer Institute

R. Ware

ACP 2024 Insights: Sickle Cell Anemia - Diagnosis and Management of …

Insights from 2024 ACP Annual Meeting

M. Okam Achebe

Hemoglobin Electrophoresis: The Normal Breakdown of Adult Hemoglobin…

Two Onc Docs

S. Armstrong, K. Tawagi

Highlights in Red Cell and Platelet Disorders From ASH 2023

Insights from 2023 ASH Annual Meeting

M. Blinder

Role of Antiplatelet and Anticoagulant Therapy: Managing Vaso-Occlus…

Erica Sparkenbaugh

Updates in Cellular Therapy for Sickle Cell Disease and Beta-Thalass…

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

S. Peslak

Outcomes of Lovo-Cel Gene Therapy in Sickle Cell Disease: 60-Month F…

Yale Cancer Center

J. Ryu

Management of Hematologic Conditions in Athletes

Scripps Health

R. Kasthuri

Recent Gene Therapy Approvals in SCD: Clinical and Logistical Consid…

Nirmish Shah

A Guide for Shared Decision Making in Sickle Cell Disease

UCSF School of Medicine

M. Treadwell

Conference Highlights: Opioids in Medically Complex Patients - Old C…

2024 Conference Highlights

A. Mishkin

Sickle Cell Disease: Epidemiology, Pathophysiology, Clinical Present…

Baystate Health

R. Steingart